Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Consolidated Net Income (2021 - 2025)

Amylyx Pharmaceuticals has reported Consolidated Net Income over the past 5 years, most recently at $111.6 million for Q4 2025.

  • Quarterly results put Consolidated Net Income at $111.6 million for Q4 2025, down 57.77% from a year ago — trailing twelve months through Dec 2025 was -$158000.0 (down 1228.57% YoY), and the annual figure for FY2025 was -$158000.0, down 1228.57%.
  • Consolidated Net Income for Q4 2025 was $111.6 million at Amylyx Pharmaceuticals, up from -$34.4 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for AMLX hit a ceiling of $264.2 million in Q4 2024 and a floor of -$118.8 million in Q1 2024.
  • Median Consolidated Net Income over the past 5 years was -$25.7 million (2021), compared with a mean of -$1.7 million.
  • Peak annual rise in Consolidated Net Income hit 2984.78% in 2024, while the deepest fall reached 7652.0% in 2024.
  • Amylyx Pharmaceuticals' Consolidated Net Income stood at -$28.3 million in 2021, then soared by 650.92% to $156.0 million in 2022, then tumbled by 94.51% to $8.6 million in 2023, then surged by 2984.78% to $264.2 million in 2024, then plummeted by 57.77% to $111.6 million in 2025.
  • The last three reported values for Consolidated Net Income were $111.6 million (Q4 2025), -$34.4 million (Q3 2025), and -$41.4 million (Q2 2025) per Business Quant data.